{
    "title": "AstraZeneca signs huge deal with UK start-up to create treatments for diabetes and other autoimmune diseases",
    "url": "https://www.dailymail.co.uk/money/markets/article-12179047/AstraZeneca-deal-start-fight-diabetes.html",
    "date": "2023-06-09",
    "keywords": [
        "deal",
        "research",
        "pharma",
        "giant",
        "astrazeneca",
        "astra",
        "cell",
        "share",
        "account",
        "fund",
        "startup",
        "firm",
        "quell",
        "licensing",
        "medicinesthe",
        "disease",
        "development",
        "vicepresident",
        "treg",
        "college",
        "treatment",
        "money",
        "drug",
        "fda",
        "nirsevimab",
        "rsv",
        "investment",
        "fee",
        "autoimmune",
        "aim",
        "type",
        "bowel",
        "use",
        "tregs",
        "shorttregs",
        "help",
        "system",
        "body",
        "technology",
        "extension",
        "cancerastra",
        "milestone",
        "executive",
        "potential",
        "iain",
        "mcgill",
        "collaboration",
        "work",
        "immune",
        "disordersquell",
        "university",
        "london",
        "school",
        "britain",
        "drugmaker",
        "boss",
        "soriot",
        "wire",
        "act",
        "time",
        "article",
        "diy",
        "consortium",
        "backer",
        "syncona",
        "trust",
        "gene",
        "expertise",
        "capability",
        "murphy",
        "chairman",
        "news",
        "tieup",
        "food",
        "administration",
        "virus",
        "infantsrsv",
        "infection",
        "coldlike",
        "illness",
        "pneumoniaif",
        "medicine",
        "look",
        "review",
        "burden",
        "reic",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}